CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 30 enrolled
Drug / intervention
Probiotic Blend +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05766306
NCT05766306Phase 2Completed

A Randomized, Double-blind, Placebo-controlled, Parallel Study Investigating the Efficacy of a Probiotic Blend on Stress in Adolescents With Moderate Perceived Stress

Lallemand Health Solutions·interventional·Posted Mar 13, 2023·Updated Feb 22, 2024

In Brief

A Phase 2 clinical trial evaluating Probiotic Blend and Placebo for Stress. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The goal of this clinical trial is to test to efficacy of a probiotic blend on stress in adolescents with moderate perceived stress. It is hypothesized that those taking the probiotic blend will have decreased levels of stress compared to those receiving the placebo.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStress
CountriesCanada
CollaboratorsKGK Science Inc.

Timeline

Phase 2CompletedFinished
202420252026
First PostedMar 13, 2023
Enrollment StartMar 15, 2023
Primary CompletionFeb 2, 2024
TodayJul 1, 2026
Enrollment to primary: 11 monthsPosted 3.3 years ago

Interventions

Probiotic Blenddietary

Participants will be taking 1 sachet a day, 3 billion CFU.

Placebodietary

Participants will be taking 1 sachet a day.